Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2003-04-01 (23 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: HATTEN (67690), Bas-Rhin
PHARMACIE GEISSERT : revenue, balance sheet and financial ratios
PHARMACIE GEISSERT is a French company
founded 23 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in HATTEN (67690),
this company of category PME
shows in 2021 a revenue of 2.1 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE GEISSERT (SIREN 448275057)
Indicator
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
2 115 861 €
2 056 504 €
2 109 502 €
1 896 744 €
1 925 717 €
2 075 081 €
Net income
131 832 €
122 962 €
85 907 €
97 688 €
94 481 €
94 545 €
135 586 €
EBITDA
N/C
161 754 €
132 911 €
151 524 €
155 488 €
160 840 €
221 295 €
Net margin
N/C
5.8%
4.2%
4.6%
5.0%
4.9%
6.5%
Revenue and income statement
In 2022, PHARMACIE GEISSERT generates positive net income of 132 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2022: 136 k€ -> 132 k€.
Net income (2022)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
131 832 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 5%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 83%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2022)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
4.561%
Financial autonomy (2022)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
83.046%
Asset age ratio (2022)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
Debt ratio
21.234
18.731
15.742
12.97
10.76
10.84
4.561
Financial autonomy
75.537
75.731
77.719
81.305
82.646
80.144
83.046
Repayment capacity
2.005
2.422
2.144
1.759
1.716
1.295
None
Cash flow / Revenue
8.144%
6.586%
6.519%
5.914%
5.085%
6.649%
None%
Sector positioning
Debt ratio
4.562022
2020
2021
2022
Q1: 24.52
Med: 74.72
Q3: 182.51
Excellent
In 2022, the debt ratio of PHARMACIE GEISSERT (4.56) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
83.05%2022
2020
2021
2022
Q1: 28.54%
Med: 47.06%
Q3: 66.61%
Excellent
In 2022, the financial autonomy of PHARMACIE GEISSERT (83.0%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
1.29 years2021
2020
2021
Q1: 1.06 years
Med: 3.56 years
Q3: 7.31 years
Good
In 2021, the repayment capacity of PHARMACIE GEISSERT (1.29) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 288.77. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2022)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
288.769
Liquidity indicators evolution PHARMACIE GEISSERT
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
Liquidity ratio
362.137
339.069
361.286
438.031
412.647
345.767
288.769
Interest coverage
2.739
3.331
2.986
2.582
2.381
1.493
None
Sector positioning
Liquidity ratio
288.772022
2020
2021
2022
Q1: 145.17
Med: 199.48
Q3: 274.99
Excellent
In 2022, the liquidity ratio of PHARMACIE GEISSERT (288.77) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
1.49x2021
2020
2021
Q1: 0.27x
Med: 2.43x
Q3: 5.92x
Average
In 2021, the interest coverage of PHARMACIE GEISSERT (1.5x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2022)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2022)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2022)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2022)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE GEISSERT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
Operating WCR
106 140 €
115 909 €
122 738 €
108 703 €
85 448 €
66 925 €
0 €
Inventory turnover (days)
19
20
22
17
17
15
0
Customer payment term (days)
7
5
6
4
5
4
0
Supplier payment term (days)
29
42
44
31
27
40
0
Positioning of PHARMACIE GEISSERT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 215 transactions of similar company sales
in 2022,
the value of PHARMACIE GEISSERT is estimated at
1 551 202 €
(range 1 042 716€ - 2 326 515€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2022
215 transactions
1042k€1551k€2326k€
1 551 202 €Range: 1 042 716€ - 2 326 515€
NAF 5 année 2022
Valuation method used
Net Income Multiple
131 832 €
×
11.8x
=1 551 202 €
Range: 1 042 716€ - 2 326 515€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE GEISSERT with other companies in the same sector:
Frequently asked questions about PHARMACIE GEISSERT
What is the revenue of PHARMACIE GEISSERT ?
The revenue of PHARMACIE GEISSERT in 2021 is 2.1 M€.
Is PHARMACIE GEISSERT profitable?
Yes, PHARMACIE GEISSERT generated a net profit of 132 k€ in 2022.
Where is the headquarters of PHARMACIE GEISSERT ?
The headquarters of PHARMACIE GEISSERT is located in HATTEN (67690), in the department Bas-Rhin.
Where to find the tax return of PHARMACIE GEISSERT ?
The tax return of PHARMACIE GEISSERT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE GEISSERT operate?
PHARMACIE GEISSERT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart